quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:58:54·87d
SECFiling
Daxor Corporation logo

Daxor Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

DXR· Daxor Corporation
Health Care
Original source

Companies

  • DXR
    Daxor Corporation
    Health Care

Related

  • INSIDER13d
    SEC Form 4 filed by Feldschuh Michael Richard
  • PR15d
    Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
  • SEC21d
    Amendment: SEC Form N-CEN/A filed by Daxor Corporation
  • INSIDER23d
    SEC Form 4 filed by Michel Robert J
  • SEC23d
    SEC Form 40-17F2 filed by Daxor Corporation
  • PR28d
    Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
  • INSIDER30d
    SEC Form 4 filed by Jefferies John
  • PR37d
    Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022